Jordi Bruna Escuer
Jordi Bruna Escuer
Unit of Neuro-Oncology. Hospital Universitari de Bellvitge-ICO l'Hospitalet.
Verified email at
Cited by
Cited by
Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial
R Stupp, S Taillibert, A Kanner, W Read, DM Steinberg, B Lhermitte, ...
Jama 318 (23), 2306-2316, 2017
Chemotherapy-induced peripheral neurotoxicity (CIPN): an update
AA Argyriou, J Bruna, P Marmiroli, G Cavaletti
Critical reviews in oncology/hematology 82 (1), 51-77, 2012
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
G Cavaletti, DR Cornblath, ISJ Merkies, TJ Postma, E Rossi, B Frigeni, ...
Annals of Oncology 24 (2), 454-462, 2013
Neuronal surface antigen antibodies in limbic encephalitis: clinical–immunologic associations
F Graus, A Saiz, M Lai, J Bruna, F López, L Sabater, Y Blanco, MJ Rey, ...
Neurology 71 (12), 930-936, 2008
Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer
AA Argyriou, G Cavaletti, C Briani, R Velasco, J Bruna, M Campagnolo, ...
Cancer 119 (2), 438-444, 2013
Rapid eye movement sleep behavior disorder and potassium channel antibody–associated limbic encephalitis
A Iranzo, F Graus, L Clover, J Morera, J Bruna, C Vilar, ...
Annals of neurology 59 (1), 178-181, 2006
Chemobrain: a systematic review of structural and functional neuroimaging studies
M Simó, X Rifà-Ros, A Rodriguez-Fornells, J Bruna
Neuroscience & Biobehavioral Reviews 37 (8), 1311-1321, 2013
Ki‐67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma
J Bruna, M Brell, I Ferrer, P Gimenez‐Bonafe, A Tortosa
Neuropathology 27 (2), 114-120, 2007
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
P Alberti, E Rossi, DR Cornblath, ISJ Merkies, TJ Postma, B Frigeni, ...
Annals of oncology 25 (1), 257-264, 2014
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients
R Velasco, J Bruna, C Briani, AA Argyriou, G Cavaletti, P Alberti, B Frigeni, ...
Journal of Neurology, Neurosurgery & Psychiatry 85 (4), 392-398, 2014
Influence of treatment with tumor-treating fields on health-related quality of life of patients with newly diagnosed glioblastoma: a secondary analysis of a randomized clinical …
MJB Taphoorn, L Dirven, AA Kanner, G Lavy-Shahaf, U Weinberg, ...
JAMA oncology 4 (4), 495-504, 2018
Voltage‐gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin‐induced peripheral neurotoxicity: Results from a prospective multicenter study
AA Argyriou, G Cavaletti, A Antonacopoulou, AA Genazzani, C Briani, ...
Cancer 119 (19), 3570-3577, 2013
Syndrome and outcome of antibody‐negative limbic encephalitis
F Graus, D Escudero, L Oleaga, J Bruna, A Villarejo‐Galende, ...
European Journal of Neurology 25 (8), 1011-1016, 2018
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients
AA Argyriou, R Velasco, C Briani, G Cavaletti, J Bruna, P Alberti, ...
Annals of oncology 23 (12), 3116-3122, 2012
Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice
J Bruna, E Udina, A Alé, JJ Vilches, A Vynckier, J Monbaliu, L Silverman, ...
Experimental neurology 223 (2), 599-608, 2010
Chemotherapy-induced peripheral neuropathy: an unresolved issue
R Velasco, J Bruna
Neurología (English Edition) 25 (2), 116-131, 2010
Cognitive and brain structural changes in a lung cancer population
M Simó, JC Root, L Vaquero, P Ripollés, J Jové, T Ahles, A Navarro, ...
Journal of Thoracic Oncology 10 (1), 38-45, 2015
Taxane-induced peripheral neurotoxicity
R Velasco, J Bruna
Toxics 3 (2), 152-169, 2015
Efficacy of a novel sigma-1 receptor antagonist for oxaliplatin-induced neuropathy: a randomized, double-blind, placebo-controlled phase IIa clinical trial
J Bruna, S Videla, AA Argyriou, R Velasco, J Villoria, C Santos, C Nadal, ...
Neurotherapeutics 15, 178-189, 2018
Anti-Hu-associated brainstem encephalitis
A Saiz, J Bruna, P Stourac, MC Vigliani, B Giometto, W Grisold, ...
Journal of Neurology, Neurosurgery & Psychiatry 80 (4), 404-407, 2009
The system can't perform the operation now. Try again later.
Articles 1–20